Each year, more than 30,000 people are diagnosed with pancreatic cancer, and nearly all will die from it. As the fourth leading cause of cancer death, doctors have been searching for answers in this hard to treat disease. Now, they may have found one.
Last December, Arnold Wroblewski joined the 30,000 people diagnosed with pancreatic cancer each year. Facing a grim diagnosis, he enrolled in a study on an experimental treatment for the disease.
"It's a new paradigm in cancer treatment. The concept is very new, very cutting edge, and very exciting," says Dr. Kenneth Chang.
That concept is the drug TNF-Erade. TNF is a cancer-fighter that occurs naturally in the body. Doctors inject the gene for TNF into the tumor to capitalize on its cancer-killing ability. It works in synergy with radiation and chemotherapy. Chemo makes radiation more effective and radiation makes TNF multiply faster.
"This represents a potential to truly advance our ability to treat and potentially cure cancers as lethal as pancreatic cancer."
Early results show 33 percent of patients who received the highest dose had their tumors shrink more than fifty percent. Nearly one year later, Arnold's tumor is gone.
"He should have, by all statistics, been dead at this time, but he is alive. He is well. He is fully functioning." "There's still something special that I need to get done to help some other less fortunate people in the world, because I've been so fortunate, so fortunate, and I can't believe why."
For more information, contact:
H. H. Chao
Comprehensive Digestive Disease Center
(888) 717-GIMD (4463)